FDA Approved: TERIFLUNOMIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Camber Pharmaceuticals’ supplemental application to authorize a generic teriflunomide product for use in treating multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Teriflunomide (teriflunomide)

Snippet

SUPPL AP for TERIFLUNOMIDE (TERIFLUNOMIDE)